We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
+65.08%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$190M
AUM Growth
+$69.9M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 93.57%
2 Communication Services 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$114M 60.06%
3,766,666
TVRD
2
Tvardi Therapeutics
TVRD
$23.5M
$42.4M 22.29%
77,752
MRSN
3
DELISTED
Mersana Therapeutics
MRSN
$21.2M 11.15%
31,858
LVO icon
4
LiveOne
LVO
$66M
$12.2M 6.43%
372,414
SENS icon
5
Senseonics Holdings Inc
SENS
$254M
$139K 0.07%
7,980

Similar funds

Rho Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Rho Capital Partners held 5 positions worth $190M, up 58% from $120M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 0%. Rho Capital Partners opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 92% a quarter earlier, followed by Communication Services.

  • Rho Capital Partners's ten largest holdings make up 100% of its $190M portfolio in Q4 2020.
  • Rho Capital Partners opened 0 new positions and closed 0 in Q4 2020.
  • Rho Capital Partners's portfolio value rose 58% quarter-over-quarter to $190M.

Based on Rho Capital Partners's 13F filing for Q4 2020, filed 10 Feb 2021.